Optimization of therapeutic strategy for esophageal squamous cell carcinoma based on modeling of intratumoral heterogeneity using omics data and genome editing
Project/Area Number |
26293304
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Partial Multi-year Fund |
Section | 一般 |
Research Field |
Digestive surgery
|
Research Institution | The University of Tokushima |
Principal Investigator |
IMOTO Issei 徳島大学, 大学院医歯薬学研究部, 教授 (30258610)
|
Co-Investigator(Kenkyū-buntansha) |
丹黒 章 徳島大学, 大学院医歯薬学研究部, 教授 (10197593)
高山 哲治 徳島大学, 大学院医歯薬学研究部, 教授 (10284994)
|
Co-Investigator(Renkei-kenkyūsha) |
YANAGAWA Hiroaki 徳島大学, 病院, 准教授 (50263827)
OTSUJI Eigo 京都府立医科大学, 医学(系)研究科, 教授 (20244600)
TAJIMA Atsushi 徳島大学, 大学院医歯薬学研究部, 准教授 (10396864)
MASUDA Kiyoshi 徳島大学, 大学院医歯薬学研究部, 准教授 (00457318)
|
Project Period (FY) |
2014-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥15,990,000 (Direct Cost: ¥12,300,000、Indirect Cost: ¥3,690,000)
Fiscal Year 2016: ¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2015: ¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2014: ¥7,020,000 (Direct Cost: ¥5,400,000、Indirect Cost: ¥1,620,000)
|
Keywords | ゲノム / オミックス / 分子プロファイリング / ゲノム編集 / 食道癌 / シミュレーション / 食道扁平上皮癌 / 癌 / 腫瘍内不均一性 |
Outline of Final Research Achievements |
To optimize therapeutic strategy overcoming the therapy resistance, recurrence, and metastasis for realizing the personalized medicine in patients with ESCC, we have detected intratumoral heterogeneity and estimated the clonal structure and its association with functional features of tumor based on the simulation by omics data modeling using tumors and plasma DNAs and experimental validation using genome editing technology. Novel molecular targets for ESCC were identified using integrated data. In addition, we have developed highly efficient mutation-introducing methods into cell lines using Crispr/Cas9 system, selected mutated clones by various reagents including anti-cancer reagents, and determined the pattern of mutations necessary for the therapy resistance in ESCC.
|
Report
(4 results)
Research Products
(51 results)
-
-
[Journal Article] Clinical utility of circulating cell-free Epstein-Barr virus DNA in patients with gastric cancer.2017
Author(s)
Shoda K, Ichikawa D, Fujita Y, Masuda K, Hiramoto H, Hamada J, Arita T, Konishi H, Kosuga T, Komatsu S, Shiozaki A, Okamoto K, Imoto I, Otsuji E.
-
Journal Title
Oncotarget
Volume: 17
Issue: 17
Pages: 28796-28804
DOI
NAID
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
-
-
-
-
[Journal Article] Monitoring the HER2 copy number status in circulating tumor DNA by droplet digital PCR in patients with gastric cancer.2017
Author(s)
Shoda K, Ichikawa D, Fujita Y, Masuda K, Hiramoto H, Hamada J, Arita T, Konishi H, Komatsu S, Shiozaki A, Kakihara N, Okamoto K, Taniguchi H, Imoto I, Otsuji E.
-
Journal Title
Gastric Cancer
Volume: 1
Issue: 1
Pages: 126-135
DOI
NAID
Related Report
Peer Reviewed / Int'l Joint Research
-
-
-
-
-
-
-
[Journal Article] MicroRNA-203 Suppresses Invasion and Epithelial-mesenchymal Transition Induction via Targeting NUAK1 and SNAI2 in Head and Neck Cancer2016
Author(s)
Obayashi, M., Yoshida, M., Tsunematsu, T., Ogawa, I., Sasahira, T., Kuniyasu, H., Imoto, I., Abiko, Y., Xu, D., Fukunaga, S., Tahara, H., Kudo, Y., Nagao, T., Takata, T.
-
Journal Title
Oncotarget
Volume: 6972
Issue: 7
Pages: 8223-39
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Tumor-promoting function and prognostic significance of the RNA-binding protein T-cell intracellular antigen-1 in esophageal squamous cell carcinoma2015
Author(s)
Hamada J, Shoda K, Masuda K, Fujita Y, Naruto T, Kohmoto T, Miyakami Y, Watanabe M, Kudo Y, Fujiwara H, Ichikawa D, Otsuji E, Imoto I
-
Journal Title
Oncotarget
Volume: -
Issue: 13
Pages: 17111-17128
DOI
NAID
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
-
-
-
-
-
-
-
[Journal Article] B-RAF mutation and accumulated gene methylation in aberrant crypt foci (ACF), sessile serrated adenoma/polyp (SSA/P) and cancer in SSA/P2015
Author(s)
Inoue A, Okamoto K, Fujino Y, Nakagawa T, Muguruma N, Sannomiya K, Mitsui Y, Takaoka T, Kitamura S, Miyamoto H, Okahisa T, Fujimori T, Imoto I, Takayama T
-
Journal Title
Br J Cancer
Volume: 112
Issue: 2
Pages: 403-412
DOI
Related Report
Peer Reviewed
-
[Journal Article] Overexpression of SMYD2 contributes to malignant outcome in gastric cancer2014
Author(s)
Komatsu S, Ichikawa D, Hirajima S, Nagata H, Nishimura Y, Kawaguchi T, Miyamae M, Okajima W, Ohashi T, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Imoto I, Inazawa J, Otsuji E
-
Journal Title
Br J Cancer
Volume: 112
Issue: 2
Pages: 357-64
DOI
Related Report
Peer Reviewed / Acknowledgement Compliant
-
-
-
[Journal Article] Hypomethylation of long interspersed nuclear element-1 (LINE-1) is associated with poor prognosis via activation of c-MET in hepatocellular carcinoma2014
Author(s)
C. Zhu, T. Utsunomiya, T. Ikemoto, S. Yamada, Y. Morine, S. Imura, Y. Arakawa, C. Takasu, D. Ishikawa, I. Imoto, and M. Shimada
-
Journal Title
Ann Surg Onco
Volume: 21
Issue: S4
Pages: 729-735
DOI
Related Report
Peer Reviewed
-
-
-
[Journal Article] The expression and clinical significance of connective tissue growth factor in advanced head and neck squamous cell cancer.2014
Author(s)
Kikuchi R, Kikuchi Y, Tsuda H, Maekawa H, Kozaki KI, Imoto I, Tamai S, Shiotani A, Iwaya K, Sakamoto M, Sekiya T, Matsubara O
-
Journal Title
Human Cell
Volume: 印刷中
Issue: 3
Pages: 121-128
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Overexpression of SMYD2 contributes to malignant outcome in gastric cancer.2014
Author(s)
Hirajima S, Komatsu S, Ichikawa D, Nagata H, Nishimura Y, Konishi H, Shiozaki A, Okamoto K, Tsuda H, Imoto I, Inazawa J, Otsuji E.
Organizer
第73回日本癌学会学術総会
Place of Presentation
パシフィコ横浜(神奈川県・横浜市)
Year and Date
2014-09-27
Related Report
-
-
-
-
-
-
-
-